US Stock MarketDetailed Quotes
VSTM Verastem
- 2.3500
- +0.1100+4.91%
Close Aug 9 16:00 ET
- 2.3200
- -0.0300-1.28%
Post 20:01 ET
94.57MMarket Cap-732P/E (TTM)
2.3850High2.2900Low284.41KVolume2.3800Open2.2400Pre Close667.97KTurnover0.76%Turnover RatioLossP/E (Static)40.24MShares14.220052wk High5.02P/B88.44MFloat Cap2.100052wk Low--Dividend TTM37.63MShs Float225.8400Historical High--Div YieldTTM4.24%Amplitude2.1000Historical Low2.3480Avg Price1Lot Size
About Verastem Company
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Company Profile
SymbolVSTM
Company NameVerastem
Listing DateJan 27, 2012
Issue Price10.00
Founded2010
CEOMr. Daniel Paterson
MarketNASDAQ
Employees73
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 500
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-781-292-4200
Websitehttp://www.verastem.com
Company Executives
- Name
- Position
- Salary
- Daniel Paterson
- Director, President and Chief Executive Officer
- 3.63M
- Daniel Calkins
- Chief Financial Officer and Chief Accounting Officer
- 622.56K
- Brian M. Stuglik, R.Ph.
- Director
- 2.02M
- Robert Gagnon, M.B.A.
- Director
- 64.29K
- Michelle Robertson
- Independent Director
- 84.29K
- Dr. Michael Glen Kauffman, M.D.,PhD
- Lead Independent Director
- 124.29K
- Dr. Karin Tollefson
- Independent Director
- 93.49K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 89.29K
- John H. Johnson
- Independent Director
- 81.29K
- Dr. Paul Bunn, M.D.
- Independent Director
- 74.29K
- Anil Kapur
- Independent Director
- 81.75K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg